We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NCH2 market cap is 1.43B. The company's latest EPS is EUR 0.0871 and P/E is 125.26.
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 254.25M | 319.5M | 383.15M | 652.8M | 862M |
| Operating Income | 27.87M | 26.99M | 8.94M | 22.3M | -13M |
| Net Income | 21.67M | 21.29M | 6.04M | 22.5M | 11M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 390.05M | 415.57M | 541.42M | 1.14B | 1.26B |
| Total Liabilities | 206.55M | 212.18M | 330M | 400.1M | 507M |
| Total Equity | 183.5M | 203.39M | 211.42M | 744.8M | 754M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 4.28M | 36.6M | 87.11M | -14.2M | -62M |
| Investing | 40.83M | -25.15M | -63.33M | 243.3M | -16M |
| Financing | -53.39M | -5.11M | -6.96M | 515.4M | -7M |
| Market Cap | 1.43B |
| Price to Earnings Ratio | 125.26 |
| Price to Sales Ratio | 1.6 |
| Price to Cash Ratio | 2.03 |
| Price to Book Ratio | 1.83 |
| Dividend Yield | - |
| Shares Outstanding | 126.32M |
| Average Volume (1 week) | 64.73k |
| Average Volume (1 Month) | 101.46k |
| 52 Week Change | -28.11% |
| 52 Week High | 16.88 |
| 52 Week Low | 7.705 |
| Spread (Intraday) | 0.05 (0.44%) |
| Company Name | Thyssenkrupp Nucera Ag & Co |
| Address |
vosskuhle 38, harpen-haus dortmund 44141 |
| Website | https://www.thyssenkrupp-nucera.com |
| Industry | chemicals & chem preps, nec (2899) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
